Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Rohatgi R"" wg kryterium: Autor


Tytuł:
Initial mean arterial blood pressure (MABP) measurement is a risk factor for mortality in hypertensive COVID-19 positive hospitalized patients.
Autorzy:
Yangchen T; Stony Brook University School of Medicine, Stony Brook, NY, United States of America.
Koraishy FM; Stony Brook University School of Medicine, Stony Brook, NY, United States of America.; Northport VAMC, Northport, NY, United States of America.
Xu C; James J. Peters VAMC, Bronx, NY, United States of America.; Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, United States of America.
Hou W; Vertex Pharmaceuticals Inc., Boston, MA, United States of America.
Rohatgi R; James J. Peters VAMC, Bronx, NY, United States of America.; Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Mar 30; Vol. 18 (3), pp. e0283331. Date of Electronic Publication: 2023 Mar 30 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
COVID-19*/complications
Hypertension*
Adult ; Humans ; Arterial Pressure ; Blood Pressure/physiology ; Risk Factors
Czasopismo naukowe
Tytuł:
Dose and Duration Dependent Effect of Fluoxetine on Dorsolateral Lobe of Prostate of Albino Rats-An Experimental Study.
Autorzy:
AGGARWAL, ALKA
JETHANI, S. L.
ROHATGI, R. K.
KALRA, JUHI
Pokaż więcej
Temat:
FLUOXETINE
SEROTONIN uptake inhibitors
PROSTATITIS
MEDICAL sciences
PROSTATE cancer
PROSTATE
CELL death
Źródło:
Journal of Clinical & Diagnostic Research; Mar2023, Vol. 17 Issue 3, p1-5, 5p
Terminy geograficzne:
UTTARAKHAND (India)
Czasopismo naukowe
Tytuł:
Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults.
Autorzy:
Dreyzin A; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
Jacobsohn D; Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
Angiolillo A; Division of Oncology, Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
Wistinghausen B; Division of Oncology, Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
Schore RJ; Division of Oncology, Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
Perez E; Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
Wells E; Neuroscience and Behavioral Medicine Center, Children's National Hospital, Washington, DC, USA.
Terao J; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
Bonifant C; Division of Oncology, Johns Hopkins Medical Institutions Campus, Baltimore, MD, USA.
Rohatgi R; Division of Pharmacy Services, Children's National Hospital, Washington, DC, USA.
Dave H; Division of Oncology, Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
Vatsayan A; Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
Pokaż więcej
Źródło:
Pediatric hematology and oncology [Pediatr Hematol Oncol] 2022 May; Vol. 39 (4), pp. 370-378. Date of Electronic Publication: 2021 Oct 21.
Typ publikacji:
Letter
MeSH Terms:
Interleukin 1 Receptor Antagonist Protein*/adverse effects
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Administration, Intravenous ; Child ; Humans ; Receptors, Antigen, T-Cell ; Young Adult
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies